Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded
- Contract number
- SPE2DB25FMWGC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,846
Award facts
- Contract value 100% obligated
- $14,845.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $14,845.54 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml syringes on July 23, 2025, with completion scheduled for July 24, 2025. This competitively awarded, firm fixed price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication primarily used to treat moderate-to-severe atopic dermatitis, eosinophilic esophagitis, and moderate-to-severe eosinophilic asthma, and this procurement supports federal medical supply needs for military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs, including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen maintains an extensive portfolio of specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains, demonstrating substantial capability to fulfill diverse federal healthcare requirements.
Quick answers
Who was awarded contract SPE2DB25FMWGC?
SPE2DB25FMWGC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 23, 2025.
How much is contract SPE2DB25FMWGC worth?
The government has obligated $14,846 on SPE2DB25FMWGC.
Is contract SPE2DB25FMWGC an order under another contract?
Yes. SPE2DB25FMWGC is a delivery order under SPE2DB20D2104, an indefinite delivery contract.
Was contract SPE2DB25FMWGC competed?
The extent of competition for SPE2DB25FMWGC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award